AhR, aryl hydrocarbon receptor
According to the MHRA/EMC SmPC, the most commonly reported side effects are gastrointestinal in nature
The relationship between GLP-1 receptor agonists and inflammatory bowel disease (IBD), including Crohns disease and ulcerative colitis, appears more complex
Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, et al
This relationship supports the hypothesis that much of tirzepatide's anti-inflammatory benefit may be mediated through weight loss rather than direct receptor-mediated anti-inflammatory signaling, though controlled studies specifically addressing this question are limited
They can recommend strategies, such eating a balanced diet or talking with a qualified therapist or registered dietitian, to give you the support you need to improve your health